Data / Form D filings / Avant Diagnostics, Inc
Avant Diagnostics, Inc: Form D filings
Avant Diagnostics, Inc, a biotechnology company in Washington, DC, filed 2 Form D notices with the SEC between 2016 and 2018. The latest, on June 13, 2018, reports $1.2 million sold of a $2 million offering to 8 investors.
Find out what Avant Diagnostics, Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1050 30TH STREET NW, SUITE 107, Washington, DC, 20007
- Phone
- (708) 710-9200
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Nevada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1451929
The full lists. Form D filings in District of Columbia: 247 rows, $12.35, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 13, 2018 | New notice | $2,000,000 | $1,165,155 | $834,845 | 8 | May 25, 2018 | sec.gov |
| Jan 20, 2016 | New notice | $112,500 | $112,500 | $0 | 1 | Jan 5, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Ruxin, M.D. | Executive Officer | |
| Scott VanderMeer | Executive Officer | |
| Jeff Busch | Director | |
| Robert Trapp | Director | |
| John Brugmann | Director | |
| Jeff Stephens | Director |
Other biotechnology companies in District of Columbia that filed recently
- OptoVista Holdings, LLC $3.7 million · Sep 25, 2026
Every Form D from the week of Jun 11, 2018 · All recent filings in District of Columbia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Avant Diagnostics, Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.